Privia Health Group, Inc. — Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports corporate governance changes at Privia Health Group, Inc. The report’s earliest event date is June 28, 2021; the director election became effective June 30, 2021. The filing does not cover a financial reporting period or provide operating results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- The Board increased from eight to nine directors.
- Jaewon Ryu, MD, JD was elected to the newly created Board seat, effective June 30, 2021.
- Dr. Ryu was appointed to the Board’s Compliance Committee and was determined to be independent under Nasdaq standards.
- Dr. Ryu will receive the standard compensation applicable to non-employee directors, including an initial restricted stock unit award valued at $175,000.
- Dr. Ryu will enter into a standard indemnification agreement with the Company.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance, operating outlook, contingencies, or risk-factor updates. The Company stated that there are no arrangements or understandings with other persons regarding Dr. Ryu’s selection and no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
The Company issued a related press release dated June 30, 2021, furnished as Exhibit 99.1 under Item 7.01. The Regulation FD information is not deemed filed for purposes of Section 18 liability or incorporated by reference except where expressly stated.
Investor Verification Checklist
- Verify the effective date of Dr. Ryu’s election and his appointment to the Compliance Committee.
- Review the $175,000 initial restricted stock unit award and the applicable non-employee director compensation terms.
- Review Exhibit 99.1 for the Company’s accompanying announcement.
- Confirm that this filing contains no current-period financial statements or changes to financial guidance.